Journal of Clinical Epidemiology
Volume 51, Issue 2 , Pages 129-135 , February 1998

Selection of Controls in Database Case-Control Studies: Glucocorticoids and the Risk of Glaucoma

  • Edeltraut Garbe

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill Pharmacoepidemiology Research Unit, McGill University, Montreal USA
    • Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal USA
    • Centre de Recherche, Hôtel-Dieu de Montréal, Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Jean-François Boivin

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill Pharmacoepidemiology Research Unit, McGill University, Montreal USA
    • ,
  • Jacques LeLorier

      Affiliations

    • Centre de Recherche, Hôtel-Dieu de Montréal, Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Samy Suissa

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill Pharmacoepidemiology Research Unit, McGill University, Montreal USA
    • Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal USA
    • Corresponding Author InformationSamy Suissa, Ph.D., Division of Clinical Epidemiology, Royal Victoria Hospital, 687, Pine Avenue West, Ross 4.29, Montreal, Quebec, Canada H3A 1A1

,Accepted 28 October 1997.

References 

  1. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety (A critique). Clin Pharm Ther. 1989;46:371–386
  2. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994;154:97–101
  3. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993;118:273–278
  4. Avorn J, Bohn RL, Mogun H, et al.  Neuroleptic drug exposure and treatment of parkinsonism in the elderly (A case-control study). Am J Med. 1995;99:48–54
  5. Skuta GL, Morgan RK. Corticosteroid-induced glaucoma. In:  Ritch R,  Shields MB,  Krupin T editor. The Glaucomas. 2. St. Louis: Mosby; 1996;p. 1177–1188
  6. Palmberg PF, Mandell A, Wilensky JT, Podos SM, Becker B. The reproducibility of the intraocular pressure response to dexamethasone. Am J Ophthalmol. 1975;80:844–856
  7. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research (The accuracy and comprehensiveness of the prescription claims database in Quebec). J Clin Epidemiol. 1995;48:999–1009
  8. WHO. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Based on the Recommendations of the Ninth Revision Conference, 1975. Geneva: World Health Organization; 1977.
  9. Frangie JP, Leibowitz HM. Steroids. Int Ophthalmol Clin. 1993;33:9–29
  10. Kanski JJ. The glaucomas. In:  Kanski JJ editors. Clinical Ophthalmology. A Systematic Approach. London: Butterworth Heinemann; 1994;p. 234
  11. Leske MC. The epidemiology of open-angle glaucoma (A review). Am J Epidemiol. 1983;118:166–191
  12. Wilson MR. Epidemiological features of glaucoma. Int Ophthalmol Clin. 1990;30:153–160
  13. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102:48–53
  14. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097–1106
  15. SAS Institute Inc . The PHREG procedure. In: SAS Technical Report P-229. SAS/STAT Software (Changes and Enhancements. Release 6.07). Cary: SAS Institute Inc; 1992;p. 435–479
  16. American College of Physicians , American Diabetes Association , American Academy of Ophthalmology . Screening guidelines for diabetic retinopathy. Ann Intern Med. 1992;116:683–685
  17. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Co; 1986;87
  18. Kass MA, Johnson T. Corticosteroid-induced glaucoma. In:  Rich R,  Shields MB,  Krupin T editor. The Glaucomas. St. Louis: C.V. Mosby Company; 1989;p. 1161–1168
  19. Hodapp EA, Kass MA. Corticosteroid-induced glaucoma. In:  Rich R,  Shields MB editor. The Secondary Glaucomas. St. Louis: CV. Mosby Company; 1982;p. 258–265
  20. Sommer A, Tielsch JM, Katz J, et al.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090–1095
  21. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851–1855
  22. Miettinen OS. The `case-control' study (Valid selection of subjects). J Chronic Dis. 1985;38:543–548
  23. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992;135:1029–1041
  24. Horwitz RI, Feinstein AR. Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med. 1978;299:1089–1094
  25. Shields MB. Glaucomas associated with ocular inflammation. In:  Shields MB editors. Textbook of Glaucoma. 3. Baltimore: Williams & Wilkins; 1992;p. 356–373
  26. David DS, Berkowitz JS. Ocular effects of topical and systemic corticosteroids. Lancet. 1969;2:149–151
  27. Grant WM. Ocular complications of drugs. Glaucoma. JAMA. 1969;207:2089–2091
  28. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies (I. Principles). Am J Epidemiol. 1992;135:1019–1028

PII: S0895-4356(97)00263-1

Journal of Clinical Epidemiology
Volume 51, Issue 2 , Pages 129-135 , February 1998

Article Tools